Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies

Cutaneous lupus erythematosus (CLE) is an autoimmune disease of the skin with significant morbidity. Current treatments are often inadequate to control disease and there are no Food and Drug Administration (FDA)-approved therapies for this potentially debilitating disease, underscoring an unmet medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Little, Alicia J., Vesely, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087060/
https://www.ncbi.nlm.nih.gov/pubmed/32226339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087060/
https://www.ncbi.nlm.nih.gov/pubmed/32226339

Ejemplares similares